TITAN PHARMACEUTICALS INC — Director's Dealing 2011

Apr 19, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2011-04-15

Reporting Person: SMITH LEY S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-15	Option to Purchase Common Stock	$1.40	A	25000	Acquired	2021-04-15	Common Stock (25000)	Direct
2011-04-15	Option to Purchase Common Stock	$1.40	A	35000	Acquired	2021-04-15	Common Stock (35000)	Direct

Footnotes

F1: These options vest in 12 equal monthly installments beginning on the grant date.